Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

3-Methylxanthine is a cGMP phosphodiesterase (PDE) inhibitor and a metabolite of theophylline (Item No. 23760) and caffeine (Item No. 14118).1,2,3 It is formed from theophylline by the cytochrome P450 (CYP) isoform CYP1A2 and from caffeine via 6A5NF-1,3-dimethyluracil, 1,3,7-trimethyluric acid, or theobromine intermediates. 3-Methylxanthine inhibits cGMP PDE in isolated guinea pig trachealis muscle with an IC50 value of 920 µM.1 It is neurotoxic to mice, inducing convulsions with an ED50 value of 1,107 nmol/kg.4
WARNING This product is not for human or veterinary use.
1. Inhibition of cyclic GMP phosphodiesterase by xanthine derivatives relaxes guinea-
2. Impact of coffee and cacao purine metabolites on neuroplasticity and neurodegenerative disease. Neurochem. Res. 44(1), 214-227 (2019).
3. Metabolism of theophylline by cDNA-
4. Neurotoxic convulsions induced by theophylline and its metabolites in mice. Biol. Pharm. Bull. 19(6), 869-872 (1996).